This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The Brigham and Women's Hospital, Inc., Case Western Reserve University, University of Washington. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Needham, MA (US) (2012)
- Basel, CH (2013)
Company Filing History:
2 out of 1,425 
1 out of 1,364 
1 out of 2,169 
Years Active: 2012-2013
Title: The Innovations of David M Lee in Osteoarthritis Research
Introduction
David M Lee, an inventor based in Basel, Switzerland, has made significant contributions to the field of osteoarthritis research. With a focus on biomarkers and diagnostic methods, his work is vital in the ongoing battle against this prevalent condition. With two patents to his name, he has demonstrated a commitment to innovation and the advancement of medical science.
Latest Patents
David M Lee’s recent patents are groundbreaking in the realm of osteoarthritis diagnosis and treatment. His first patent, titled "Secreted phospholipase A2 biomarkers for arthritis," relates to the use of protein expression profiles of sPLA2 isoforms that hold clinical relevance to osteoarthritis (OA). This invention provides methods for diagnosing OA and determining risk factors for its development, specifically based on the expression of sPLA2-IIA.
His second patent, "Method of diagnosing osteoarthritis," focuses on identifying and utilizing protein expression profiles in OA. This invention outlines methods and kits for studying and diagnosing OA, gauging its advancement, and selecting or monitoring treatment regimens. Furthermore, it encompasses the screening of drugs that can modulate the expression of these proteins, opening avenues for disease-modifying OA agents.
Career Highlights
Throughout his career, David M Lee has been associated with prestigious institutions, such as The Brigham and Women's Hospital and Case Western Reserve University. His work in these establishments has facilitated advancements in medical science and brought forth influential innovations in the field.
Collaborations
Collaboration is a key aspect of David's work, and he has partnered with notable colleagues, including Reuben Gobezie and Eric Boilard. Their combined expertise has played a crucial role in expanding knowledge and fostering breakthroughs in osteoarthritis research.
Conclusion
David M Lee’s contributions to the field of osteoarthritis through his patents and collaborative efforts underscore the importance of innovation in medicine. His work not only enhances diagnostic methods but also paves the way for new treatment strategies, demonstrating the profound impact inventors can have on healthcare and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile